These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16010539)

  • 21. Effect of ecstasy use on neuropsychological function: a study in Hong Kong.
    Yip JT; Lee TM
    Psychopharmacology (Berl); 2005 May; 179(3):620-8. PubMed ID: 15650845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal and visual source memory deficits among ecstasy/polydrug users.
    Fisk JE; Gallagher DT; Hadjiefthyvoulou F; Montgomery C
    Hum Psychopharmacol; 2014 Mar; 29(2):172-82. PubMed ID: 24446108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory.
    Murphy PN; Erwin PG; Maciver L; Fisk JE; Larkin D; Wareing M; Montgomery C; Hilton J; Tames FJ; Bradley B; Yanulevitch K; Ralley R
    Hum Psychopharmacol; 2011 Oct; 26(7):460-9. PubMed ID: 21898599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological indices of response inhibition in human polydrug users.
    Roberts CA; Fairclough S; Fisk JE; Tames FT; Montgomery C
    J Psychopharmacol; 2013 Sep; 27(9):779-89. PubMed ID: 23803689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE; Montgomery C; Murphy PN
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERP evidence suggests executive dysfunction in ecstasy polydrug users.
    Roberts CA; Fairclough SH; Fisk JE; Tames F; Montgomery C
    Psychopharmacology (Berl); 2013 Aug; 228(3):375-88. PubMed ID: 23532375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visuospatial working memory impairment in current and previous ecstasy/polydrug users.
    Fisk JE; Montgomery C; Hadjiefthyvoulou F
    Hum Psychopharmacol; 2011; 26(4-5):313-21. PubMed ID: 22700465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiological indices of altered working memory processes in long-term ecstasy users.
    Nulsen C; Fox A; Hammond G
    Hum Psychopharmacol; 2011 Oct; 26(7):488-97. PubMed ID: 21953632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users.
    Roberts CA; Montgomery C
    J Psychopharmacol; 2015 Nov; 29(11):1170-81. PubMed ID: 26333432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.
    Murphy PN; Wareing M; Fisk JE; Montgomery C
    Neuropsychobiology; 2009; 60(3-4):159-75. PubMed ID: 19893333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ; Raj V; Lee J; Dietrich MS; Cao A; Blackford JU; Salomon RM; Park S; Benningfield MM; Di Iorio CR; Cowan RL
    Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G; Redman J
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visuospatial memory impairments in users of MDMA ('ecstasy').
    Wareing M; Murphy PN; Fisk JE
    Psychopharmacology (Berl); 2004 May; 173(3-4):391-7. PubMed ID: 14735294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.